Basic Information
Gene ID
AALBA5B111217
Position
aalba5_s00070552:13681-16107 (-)
2426bp
Gene Type
gene
Gene Description (Protein Product)
Destroys radicals which are normally produced within the cells and which are toxic to biological systems
Organism
Also AS AT1G08830

Gene Structure

upstream:

Domain
Database EntryID E-Value Start end InterPro ID Description

Regulation&Interaction
Protein-protein interaction (PPI)
AALBA5B208170 Destroys radicals which are normally produced within the cells and which are toxic to biological systems
AALBA5B723747 Destroys radicals which are normally produced within the cells and which are toxic to biological systems
AALBA5B184062 Destroys radicals which are normally produced within the cells and which are toxic to biological systems
Regulatory gene
AALBA5B023305 dof zinc finger protein
AALBA5B027223 WRKY Transcription Factor
AALBA5B039591 WRKY Transcription Factor

Load All Networks

Annotation

Orthologous Group
Orthologous ID Species Number All hits in PereRegDB Hits of this species Orthologous Detail


Pathway
GO Term Description GO Category
GO:0000302 response to reactive oxygen species BP
GO:0000303 response to superoxide BP
GO:0000305 response to oxygen radical BP
GO:0003674 molecular_function MF
GO:0003824 catalytic activity MF
GO:0004784 superoxide dismutase activity MF
GO:0005488 binding MF
GO:0005507 copper ion binding MF
GO:0005575 cellular_component CC
GO:0005576 extracellular region CC
GO:0005615 extracellular space CC
GO:0005622 intracellular anatomical structure CC
GO:0005623 obsolete cell CC
GO:0005737 cytoplasm CC
GO:0006801 superoxide metabolic process BP
GO:0006950 response to stress BP
GO:0006979 response to oxidative stress BP
GO:0008150 biological_process BP
GO:0008152 metabolic process BP
GO:0008270 zinc ion binding MF
GO:0009636 response to toxic substance BP
GO:0009987 cellular process BP
GO:0010035 response to inorganic substance BP
GO:0016209 antioxidant activity MF
GO:0016491 oxidoreductase activity MF
GO:0016721 oxidoreductase activity, acting on superoxide radicals as acceptor MF
GO:0019430 removal of superoxide radicals BP
GO:0033554 cellular response to stress BP
GO:0034599 cellular response to oxidative stress BP
GO:0034614 cellular response to reactive oxygen species BP
GO:0042221 response to chemical BP
GO:0043167 ion binding MF
GO:0043169 cation binding MF
GO:0044237 cellular metabolic process BP
GO:0044421 obsolete extracellular region part CC
GO:0044424 obsolete intracellular part CC
GO:0044464 obsolete cell part CC
GO:0046872 metal ion binding MF
GO:0046914 transition metal ion binding MF
GO:0050896 response to stimulus BP
GO:0051716 cellular response to stimulus BP
GO:0055114 obsolete oxidation-reduction process BP
GO:0070887 cellular response to chemical stimulus BP
GO:0071450 cellular response to oxygen radical BP
GO:0071451 cellular response to superoxide BP
GO:0072593 reactive oxygen species metabolic process BP
GO:0097237 cellular response to toxic substance BP
GO:0098754 detoxification BP
GO:0098869 cellular oxidant detoxification BP
GO:1901700 response to oxygen-containing compound BP
GO:1901701 cellular response to oxygen-containing compound BP
GO:1990748 cellular detoxification BP
KEGG Term Name Description
map04146 Peroxisome Peroxisomes are essential organelles that play a key role in redox signalling and lipid homeostasis. They contribute to many crucial metabolic processes such as fatty acid oxidation, biosynthesis of ether lipids and free radical detoxification. The biogenesis of peroxisomes starts with the early peroxins PEX3, PEX16 and PEX19 and proceeds via several steps. The import of membrane proteins into peroxisomes needs PEX19 for recognition, targeting and insertion via docking at PEX3. Matrix proteins in the cytosol are recognized by peroxisomal targeting signals (PTS) and transported to the docking complex at the peroxisomal membrane. Peroxisomes' deficiencies lead to severe and often fatal inherited peroxisomal disorders (PD). PDs are usually classified in two groups. The first group is disorders of peroxisome biogenesis which include Zellweger syndrome, and the second group is single peroxisomal enzyme deficiencies.